An in vivo systematic genetic analysis of tumour progression in Drosophila - RNAi line: 16625

Metastasis is the leading cause of death for cancer patients. Consequently it is imperative that we improve our understanding of the molecular mechanisms that underlie progression of tumour growth towards malignancy. Advances in genome characterisation technologies have been very successful in identifying commonly mutated or misregulated genes in a variety of human cancers. A major challenge however is the translation of these findings to new biological insight due to the difficulty in evaluating whether these candidate genes drive tumour progression. Using the genetic amenability of Drosophila melanogaster we generated tumours with specific genotypes in the living animal and carried out a detailed systematic loss-of-function analysis to identify numerous conserved genes that enhance or suppress epithelial tumour progression. This enabled the discovery of functional cooperative regulators of invasion and the establishment of a network of conserved ‘invasion suppressors’.

RNAi line: 16625 (III)
Source: VDRC

Name: CG2135
Full name: β glucuronidase
Also known as: βGlu, Glu
Annotation symbol: CG2135
FlyBase ID: FBgn0270927

File naming convention: File names typically contain representations of date (DDMMYY), RNAi Line, Animal Number and, in some cases, window (to accommodate larger samples that require multiple image stacks)

Included files: 171014_lgl_16625_An6_combined.tif 221014_Lgl16625An8_combined.tif 231014_An8_16625_w_combined.tif 241014_lgl_16625_An10_combined.tif 28.10.14_An1_16625_w1_combined.tif 28.10.14_An1_16625_w2_combined.tif